Hospital News and Research

RSS

Molecular imaging fusion with CT anatomy results in precise localization of parathyroid lesions: Research

SNM's 2010 Image of the Year illustrates the potential of hybrid molecular imaging to provide precise information about the location and function of a condition known as "hyperparathyroidism." Researchers selected this image from more than 1,500 studies presented over the course of four days during SNM's 57th Annual Meeting in Salt Lake City.

16 Jun 2010

3 new genes in genetic research of suicidal behaviour

Three genes that have barely been studied to date have now provided fresh knowledge about patients with suicidal backgrounds. This is the result of a study by a team of Spanish researchers at Mount Sinai Hospital and Columbia University in the City of New York (United States), which found that several mutations are involved. This finding could help to develop future genetic tests to identify predisposition to suicide, without ignoring the importance of social and cultural factors.

16 Jun 2010

NTI to grant $2.8 million to promising trauma studies

The National Trauma Institute, a non-profit organization dedicated to funding trauma research in the United States, will grant $2.8 million to promising trauma studies. In its second national request for proposals, NTI seeks rigorous clinical studies, especially those addressing hemorrhage, intensive care, trauma systems or pre-hospital care.

16 Jun 2010

Norgine to develop and commercialize Tranzyme's ulimorelin ghrelin agonist

Tranzyme Pharma, a clinical-stage biopharmaceutical company, and Norgine B.V., a European specialty pharmaceutical company, announced today that they have entered into a licensing agreement that provides Norgine with the exclusive rights to develop and commercialize Tranzyme's novel ghrelin agonist, ulimorelin (TZP-101), in Europe, Australia, New Zealand, the Middle East, South Africa and North Africa. Ulimorelin is entering Phase 3 development for the treatment of gastrointestinal dysmotility conditions in acute care settings.

16 Jun 2010

European market for continuous glucose monitoring to reach $52M in 2016

The continuous glucose monitoring (CGM) market is in its development stage. The primary factor leading to the growth of the (CGM) market in Europe is the need for an easy-to-use and patient-friendly glucose-monitoring device. The traditional method of monitoring glucose was difficult and inconvenient for patients. The CGM method is not only hassle-free, but also gives a better diagnosis of diabetes.

16 Jun 2010

Vaccination against 2009 H1N1 influenza virus may also protect against 1918 Spanish influenza virus

Researchers at Mount Sinai School of Medicine have determined people who were vaccinated against the 2009 H1N1 influenza virus may also be protected against the lethal 1918 Spanish influenza virus, which killed more than 50 million people worldwide. The new findings are published in the current issue of Nature Communications.

16 Jun 2010

Synthetic sutures less painful than natural "catgut" sutures after vaginal birth

Synthetic sutures appear to cause less pain than natural "catgut" sutures in women who receive stitches after a vaginal birth, according to a new review of studies.

16 Jun 2010

University of Montreal scientists discover free radical mechanism to viral invasion

Canadian researchers have discovered a new way the body combats respiratory viral infections. In the prestigious journal PLoS Pathogens, scientists from the University of Montreal and the University of Montreal Hospital Research Center explain how the NOX2 molecule, an enzyme that generates a burst of highly reactive oxygen derivatives (or free radicals), activates defense genes and molecules when viruses invade lung cells.

16 Jun 2010

Study examines survival rates of CF patients with MRSA

A team of researchers led by Elliott Dasenbrook, MD, MHS, Assistant Professor of Medicine and Pediatrics at Case Western Reserve University School of Medicine and Associate Director of the Adult Cystic Fibrosis Program at University Hospitals Case Medical Center's Rainbow Babies & Children's Hospital today published the findings from a major study about cystic fibrosis survival rates in the June 16 issue of JAMA.

16 Jun 2010

Acclaimed virologist delivers the 2010 Leeuwenhoek prize lecture

Acclaimed virologist Robert Webster, Ph.D., of St. Jude Children's Research Hospital, presented the 2010 Leeuwenhoek prize lecture today, a prestigious recognition awarded by the Royal Society in London.

16 Jun 2010

Apollo Health Street announces second agreement with MCHS

Apollo Health Street, a developer of world-class solutions that tackle healthcare's toughest financial and IT challenges, announced today a second agreement with Mississippi County Hospital System which comprises two hospitals - SMC Regional Medical Center in Osceola, AR and Great River Medical Center in Blytheville, AR.

16 Jun 2010

BIOTRONIK announces 10th anniversary of world's first wireless, mobile patient monitoring technology

BIOTRONIK SE & Co KG, the pioneer in wireless remote monitoring technology for patients with cardiac devices, today announced the tenth anniversary of BIOTRONIK Home Monitoring®—the world's first wireless, mobile patient monitoring technology—to be celebrated during Cardiostim in Nice, France.

16 Jun 2010

Study validates Grm1 protein as target for melanoma treatment

Research by investigators at The Cancer Institute of New Jersey (CINJ) is showing new promise in the treatment of melanoma, the most serious of skin cancers. The findings, published in the May 27, 2010, online edition of the Journal of Investigative Dermatology further validate the team's clinical and pre-clinical findings that blocking the signaling normally activated by a receptor called Grm1 results in decreased cell growth and decreased migration of melanoma cells, confirming that Grm1 is a potential target for the treatment of melanoma.

16 Jun 2010

New data from Phase 2a trial support further development of BMS-945429/ALD518 monoclonal antibody for RA

Bristol-Myers Squibb Company and Alder Biopharmaceuticals today announced that new data from a dose-ranging Phase 2a trial support further development of BMS-945429/ALD518, an investigational monoclonal antibody directed against interleukin-6 (IL-6), as a potential treatment for rheumatoid arthritis (RA). The Phase 2a data will be presented in a scientific session on June 18, 2010, at the Annual Congress of the European League against Rheumatism (EULAR).

16 Jun 2010

New data shows Ohio children with special health care needs have inadequate insurance coverage

A third of Ohio children with special health care needs have unstable or inadequate insurance coverage despite the fact that they may qualify for government health programs, according to a new data analysis by the Child Policy Research Center at Cincinnati Children's Hospital Medical Center.

16 Jun 2010

Combination of BRAF-targeted therapy and immunotherapy shows promise for treatment of melanoma

Combined targeted therapy against the BRAF/MAPK pathway with immunotherapy shows promise as a new therapeutic approach for the treatment of melanoma, according to results of a preclinical study published in Cancer Research, a journal of the American Association for Cancer Research.

16 Jun 2010

European Commission grants Orphan Medicinal Product Designation for QPI-1002

Quark Pharmaceuticals, Inc., a world leader in the discovery and development of RNAi-based therapeutics, today announced that the European Commission has granted Orphan Medicinal Product Designation for QPI-1002 (also referred to as "I5NP") for the prophylaxis of delayed graft function in kidney transplant patients.

16 Jun 2010

Hospital News and Research

Molecular imaging fusion with CT anatomy results in precise localization of parathyroid lesions: Research

3 new genes in genetic research of suicidal behaviour

NTI to grant $2.8 million to promising trauma studies

Norgine to develop and commercialize Tranzyme's ulimorelin ghrelin agonist

European market for continuous glucose monitoring to reach $52M in 2016

Vaccination against 2009 H1N1 influenza virus may also protect against 1918 Spanish influenza virus

Synthetic sutures less painful than natural "catgut" sutures after vaginal birth

University of Montreal scientists discover free radical mechanism to viral invasion

Study examines survival rates of CF patients with MRSA

Acclaimed virologist delivers the 2010 Leeuwenhoek prize lecture

Apollo Health Street announces second agreement with MCHS

BIOTRONIK announces 10th anniversary of world's first wireless, mobile patient monitoring technology

Study validates Grm1 protein as target for melanoma treatment

New data from Phase 2a trial support further development of BMS-945429/ALD518 monoclonal antibody for RA

New data shows Ohio children with special health care needs have inadequate insurance coverage

Combination of BRAF-targeted therapy and immunotherapy shows promise for treatment of melanoma

European Commission grants Orphan Medicinal Product Designation for QPI-1002

UT Southwestern head and neck cancer surgeons perform area's first transoral robotic surgery

Vitamin D may help reduce incidence, severity of viral respiratory tract infections: Study

New cancer research centre launched in Edinburgh

Industry Focus eBook - Analytical Chemistry (2nd Edition) eBook

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Latest News